日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus

系统性红斑狼疮患者血清中针对谷氨酸/NMDA受体NR2A肽的自身抗体

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.2004.029280
Husebye, E S; Sthoeger, Z M; Dayan, M; Zinger, H; Elbirt, D; Levite, M; Mozes, E
信号转导
红斑狼疮
免疫/内分泌
发表日期：2005
文献求助 收藏

Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients

在移植了系统性红斑狼疮（SLE）患者外周血淋巴细胞的重症联合免疫缺陷（SCID）小鼠中，基于自身抗体互补决定区1的肽段可改善狼疮症状

期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1111/j.1365-2249.2004.02559.x
Mauermann, N; Sthoeger, Z; Zinger, H; Mozes, E
细胞生物学
红斑狼疮
免疫/内分泌
发表日期：2004
文献求助 收藏

Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies

抗雌激素他莫昔芬对（NZBxNZW）F1雌性小鼠系统性红斑狼疮的有益作用与IgG3自身抗体的特异性减少有关。

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.62.4.341
Sthoeger, Z M; Zinger, H; Mozes, E
IgG
IgG3
红斑狼疮
免疫/内分泌
发表日期：2003
文献求助 收藏

Modulation of autoreactive responses of peripheral blood lymphocytes of patients with systemic lupus erythematosus by peptides based on human and murine anti-DNA autoantibodies.

利用基于人类和鼠抗DNA自身抗体的肽调节系统性红斑狼疮患者外周血淋巴细胞的自身反应

期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1046/j.1365-2249.2003.02058.x
Sthoeger Z M, Dayan M, Tcherniack A, Green L, Toledo S, Segal R, Elkayam O, Mozes E
细胞生物学
红斑狼疮
Human
发表日期：2003
文献求助 收藏

Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus

系统性红斑狼疮患者血清中基质金属蛋白酶-9的活性升高

期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1046/j.1365-2249.2002.01758.x
Faber-Elmann, A; Sthoeger, Z; Tcherniack, A; Dayan, M; Mozes, E
红斑狼疮
免疫/内分泌
发表日期：2002
文献求助 收藏

The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus

基于致病性抗DNA自身抗体互补决定区1的肽段改善实验性系统性红斑狼疮的机制

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.98.3.1148
Eilat, E; Dayan, M; Zinger, H; Mozes, E
红斑狼疮
免疫/内分泌
发表日期：2001
文献求助 收藏

The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes.

通过不同途径给药的双重改变肽配体对实验性自身免疫性重症肌无力相关反应的主动抑制作用的性质

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.221456798
Paas-Rozner M, Sela M, Mozes E
其它
发表日期：2001
文献求助 收藏

Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes

修饰肽配体通过抑制由致肌无力T细胞表位诱导的磷脂酶C活性，发挥部分激动剂的作用。

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.95.24.14320
Faber-Elmann, A; Paas-Rozner, M; Sela, M; Mozes, E
细胞生物学
T细胞
T细胞
免疫/内分泌
发表日期：1998
文献求助 收藏

Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody

利用基于致病性抗DNA单克隆抗体互补决定区的肽段调节小鼠系统性红斑狼疮

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.94.9.4620
Waisman, A; Ruiz, P J; Israeli, E; Eilat, E; Könen-Waisman, S; Zinger, H; Dayan, M; Mozes, E
单克隆抗体
红斑狼疮
免疫/内分泌
发表日期：1997
文献求助 收藏

The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations

他莫昔芬和抗雌二醇抗体治疗对实验性系统性红斑狼疮的有益作用与细胞因子调节有关。

期刊:Immunology
影响因子:5
doi:10.1046/j.1365-2567.1997.00122.x
Dayan, M; Zinger, H; Kalush, F; Mor, G; Amir-Zaltzman, Y; Kohen, F; Sthoeger, Z; Mozes, E
细胞生物学
红斑狼疮
免疫/内分泌
发表日期：1997
文献求助 收藏